Teva Pharmaceuticals
TEVA
TEVA
772 hedge funds and large institutions have $29.6B invested in Teva Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 60 funds opening new positions, 254 increasing their positions, 309 reducing their positions, and 65 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
8% less first-time investments, than exits
New positions opened: 60 | Existing positions closed: 65
4% less funds holding in top 10
Funds holding in top 10: 49 → 47 (-2)
18% less repeat investments, than reductions
Existing positions increased: 254 | Existing positions reduced: 309
Holders
772
Holding in Top 10
47
Calls
$1.34B
Puts
$589M
Top Buyers
| 1 | +$382M | |
| 2 | +$263M | |
| 3 | +$249M | |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$145M |
| 5 |
SCM
Scopia Capital Management
New York
|
+$143M |
Top Sellers
| 1 | -$507M | |
| 2 | -$166M | |
| 3 | -$151M | |
| 4 |
Bank of New York Mellon
New York
|
-$134M |
| 5 |
PC
PointState Capital
New York
|
-$112M |